中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
30期
47-50
,共4页
中风防治灵Ⅰ号、Ⅱ号%脑梗死%二级预防%临床观察
中風防治靈Ⅰ號、Ⅱ號%腦梗死%二級預防%臨床觀察
중풍방치령Ⅰ호、Ⅱ호%뇌경사%이급예방%림상관찰
Zhongfeng Fangzhi Ling Granule 1%2%Cerebral Infarction%Secondary Prevention%Clinical effect
目的:探讨中风防治灵Ⅰ号、Ⅱ号方在脑梗死二级预防中的作用,为脑梗死二级预防提供一种新的选择.方法:将160例脑梗死患者采用随机数字表法分为对照组80例和治疗组80例.对照组予基础治疗.治疗组在基础治疗的基础上,辨证属风火上扰、风痰火亢、痰热腑实、气虚血瘀、阴虚风动五个证型者加服中风防治灵Ⅰ号,属风痰瘀阻、痰湿蒙神两个证型者加服中风防治灵Ⅱ号.观察两组脑血管事件的发生率,平均随访1年.结果:最后153例完成试验,其中对照组75例,试验组78例.对照组各事件的累积发病率21.3%,脑梗死10.7%,短暂性脑缺血发作(TIA)9.3%,脑出血1.3%,总死亡率4.0%,因事件死亡率2.7%;试验组分别为总事件7.7%,脑梗死2.6%,短暂性脑缺血发作(TIA)3.9%,脑出血1.3%,总死亡率2.6%,因事件死亡率1.3%.两组对比,短暂性脑缺血发作(TIA)、脑出血、总死亡率、因事件死亡率均无统计学意义(P>0.05);而发生脑血管事件的累积发病率、脑梗死、缺血性脑血管事件的发生(包括脑梗死及TIA),对比两组资料,则显示出,差异有统计学意义(P<0.05).结论:中风防治灵Ⅰ号、Ⅱ号能降低脑血管事件特别是脑缺血性事件的发生率,而不增加脑出血和死亡的风险,对脑梗死的二级预防作用明显,可广泛应用于临床.
目的:探討中風防治靈Ⅰ號、Ⅱ號方在腦梗死二級預防中的作用,為腦梗死二級預防提供一種新的選擇.方法:將160例腦梗死患者採用隨機數字錶法分為對照組80例和治療組80例.對照組予基礎治療.治療組在基礎治療的基礎上,辨證屬風火上擾、風痰火亢、痰熱腑實、氣虛血瘀、陰虛風動五箇證型者加服中風防治靈Ⅰ號,屬風痰瘀阻、痰濕矇神兩箇證型者加服中風防治靈Ⅱ號.觀察兩組腦血管事件的髮生率,平均隨訪1年.結果:最後153例完成試驗,其中對照組75例,試驗組78例.對照組各事件的纍積髮病率21.3%,腦梗死10.7%,短暫性腦缺血髮作(TIA)9.3%,腦齣血1.3%,總死亡率4.0%,因事件死亡率2.7%;試驗組分彆為總事件7.7%,腦梗死2.6%,短暫性腦缺血髮作(TIA)3.9%,腦齣血1.3%,總死亡率2.6%,因事件死亡率1.3%.兩組對比,短暫性腦缺血髮作(TIA)、腦齣血、總死亡率、因事件死亡率均無統計學意義(P>0.05);而髮生腦血管事件的纍積髮病率、腦梗死、缺血性腦血管事件的髮生(包括腦梗死及TIA),對比兩組資料,則顯示齣,差異有統計學意義(P<0.05).結論:中風防治靈Ⅰ號、Ⅱ號能降低腦血管事件特彆是腦缺血性事件的髮生率,而不增加腦齣血和死亡的風險,對腦梗死的二級預防作用明顯,可廣汎應用于臨床.
목적:탐토중풍방치령Ⅰ호、Ⅱ호방재뇌경사이급예방중적작용,위뇌경사이급예방제공일충신적선택.방법:장160례뇌경사환자채용수궤수자표법분위대조조80례화치료조80례.대조조여기출치료.치료조재기출치료적기출상,변증속풍화상우、풍담화항、담열부실、기허혈어、음허풍동오개증형자가복중풍방치령Ⅰ호,속풍담어조、담습몽신량개증형자가복중풍방치령Ⅱ호.관찰량조뇌혈관사건적발생솔,평균수방1년.결과:최후153례완성시험,기중대조조75례,시험조78례.대조조각사건적루적발병솔21.3%,뇌경사10.7%,단잠성뇌결혈발작(TIA)9.3%,뇌출혈1.3%,총사망솔4.0%,인사건사망솔2.7%;시험조분별위총사건7.7%,뇌경사2.6%,단잠성뇌결혈발작(TIA)3.9%,뇌출혈1.3%,총사망솔2.6%,인사건사망솔1.3%.량조대비,단잠성뇌결혈발작(TIA)、뇌출혈、총사망솔、인사건사망솔균무통계학의의(P>0.05);이발생뇌혈관사건적루적발병솔、뇌경사、결혈성뇌혈관사건적발생(포괄뇌경사급TIA),대비량조자료,칙현시출,차이유통계학의의(P<0.05).결론:중풍방치령Ⅰ호、Ⅱ호능강저뇌혈관사건특별시뇌결혈성사건적발생솔,이불증가뇌출혈화사망적풍험,대뇌경사적이급예방작용명현,가엄범응용우림상.
Objective: To explore the effect of Zhongfeng Fangzhi Ling Granule 1,2 for the secondary prevention of cerebralinfarction.Method: 160 enrolled cases were randomly divided into the treatment group and the control group with 80 in each.The control group was given basic treatment,while the treatment group was treated based on the basic treatment.The cases with TCM syndromes wind-fire rising,excession of wind phlegm-fire,Qi Deficiency and Blood Stasis,Yin Deficiency and wind movement were treated with Zhongfeng Fangzhi Ling Granule 1; and Zhongfeng Fangzhi Ling Grangule 2 was given to the cases with TCM syndromes of Wind-phlegm Syndrome,phlegm-wetness with the coma type.The incidence rate of the two groups were observed and the cases were followed up for 1 year.Results: 153 subjects have finished the study (78 in the experimental group and 75 in the control group).In test group the cumulative incidence rate was 21.3% (cerebral infraction10.7%,transient ischemic attack (TIA)9.3%,Cerebral Hemorrhage 1.3%).The total mortality rate was 4.0%,death caused by cerebro-cardiovascular accidents was 2.7%; But in control group the cumulative incidence risk of each event was 7.69% (2.6%,3.9%,1.3%),2.6%,1.28%.Between the two groups,there were no obviously statistical differences in transient ischemic attack(TIA),cerebral hemorrhage,total mortality rate,death caused by cerebro-cardiovascular accidents(P>0.05); but there was statistical significance in cumulative incidence rate,cerebral infraction,ischemic cerebrovascular event(cerebral infraction and TIA)(P<0.05).Conclusion: Zhongfeng Fangzhi Ling Granule 1,2 can reduce the incidence of cerebrovascular,especially ischemic cerebrovascular event without increasing the risk of cerebral hemorrhage and mortality rate.Therefore Zhongfeng Fangzhi Ling Granule 1,2 have significant influence on the Secondary Prevention of cerebral infarction and can be widely applied.